Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13775)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2017 (publication date) through Dec 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Oh EH, Ko DH, Seo H, Chang K, Kim GU, Song EM, Seo M, Lee HS, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park SH. Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease. World J Gastroenterol 2017; 23(8): 1489-1496 [PMID: 28293096 DOI: 10.3748/wjg.v23.i8.1489] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i8/1489.htm |
| Number | Citing Articles |
| 1 |
Sang Hyoung Park, Satimai Aniwan, Edward V Loftus. Advances in the use of biologics and other novel drugs for managing inflammatory bowel disease. Current Opinion in Pharmacology 2017; 37: 65 doi: 10.1016/j.coph.2017.09.007
|
| 2 |
Hyungil Seo, Byong Duk Ye, Eun Mi Song, Sun-Ho Lee, Kiju Chang, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang. Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn’s Disease: A Hospital-Based Cohort Study from Korea. Digestive Diseases and Sciences 2017; 62(10): 2882 doi: 10.1007/s10620-017-4715-7
|
| 3 |
Mathilde Barrau, Manon Duprat, Pauline Veyrard, Quentin Tournier, Nicolas Williet, Jean Marc Phelip, Louis Waeckel, Adam S Cheifetz, Konstantinos Papamichael, Xavier Roblin, Stephane Paul. A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2023; 17(4): 633 doi: 10.1093/ecco-jcc/jjac164
|
| 4 |
Gloria S. Z. Tun, Robert Downey, Kerry Robinson, Alison Wright, Laura Marshall, Kristina Emsell, Kirsty Swallow, Graeme Wild, Alenka J. Brooks, Thean S. Chew, Melissa F. Hale, Ravishankar Sargur, Alan J. Lobo. High prevalence of antibodies to infliximab and their relation to clinical outcomes in inflammatory bowel disease patients. GastroHep 2019; 1(5): 214 doi: 10.1002/ygh2.363
|
| 5 |
Steven J. Bots, Claire E. Parker, Johannan F. Brandse, Mark Löwenberg, Brian G. Feagan, William J. Sandborn, Vipul Jairath, Geert D’Haens, Niels Vande Casteele. Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. BioDrugs 2021; 35(6): 715 doi: 10.1007/s40259-021-00507-5
|
| 6 |
Sang Hyoung Park, Badr Al-Bawardy, Satimai Aniwan, Sunanda V Kane, Nayantara Coelho-Prabhu, Konstantinos A Papadakis, John B Kisiel, David H Bruining, William A Faubion, Laura E Raffals, Darrell S Pardi, William J Tremaine, Michael C Stephens, Jeanne Tung, Sahil Khanna, Maria Alice V Willrich, Edward V Loftus. Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2019; 1(3) doi: 10.1093/crocol/otz047
|
| 7 |
Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang. Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?. Gut and Liver 2022; 16(1): 138 doi: 10.5009/gnl210246
|
| 8 |
Hussein Hazim Saleh, Dheyaa Jabbar Khadim , Raghad Jawad Hussein. Correlation between Therapeutic Drug Monitoring of Infliximab Serum Trough Levels and other Biomarkers in Iraqi Patients with Crohn's Disease. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) 2024; 6(1): 239 doi: 10.54133/ajms.v6i1.606
|
| 9 |
Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal. Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease. Clinics 2019; 74: e824 doi: 10.6061/clinics/2019/e824
|